Lumicell Appoints Brent Palmisano Chief Commercial Officer, Builds Commercial Team

Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced it is building a commercial team to prepare for market launch of the Lumicell Direct Visualization System (DVS), which includes its novel optical imaging agent LUMISIGHT, upon FDA approval. The company appointed industry veterans Brent Palmisano as chief commercial officer and Lauren Cohen as vice president of marketing and communications.

“Brent and Lauren’s experience in launching women’s health and medical device technologies will be instrumental as we focus on bringing our innovative Lumicell DVS to market,” said Kevin Hershberger, president and chief executive officer of Lumicell. “Lumicell is at an incredible inflection point. Robust data from clinical trials enrolling more than 700 breast cancer patients have shown our Lumicell DVS has the potential to improve care, and we’re excited to build a world class commercial organization to bring this technology to surgeons and patients.”

Palmisano brings more than 20 years of experience to Lumicell and has a demonstrated track record in building and leading medical device commercial organizations. Cohen has more than 25 years of experience managing global integrated marketing and communications across new product launches, expanded indications and commercialization at industry-leading and start-up medical device organizations.